Recommendations for Biomarker Identification and Qualification in Clinical ProteomicsHarald Mischak, Antonia Vlahou, Joshua J. Coon et al.|Science Translational Medicine|2010Cited by 335
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center StudyMaria Frantzi, Nicholas P. Anagnou, Kim E. van Kessel et al.|Clinical Cancer Research|2016Cited by 104
Proteomics based identification of KDM5 histone demethylases associated with cardiovascular diseaseMarika Mokou, Antonia Vlahou|EBioMedicine|2019Cited by 46
Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelinesBernd J. Schmitz‐Dräger, Lambertus A. Kiemeney, Eva Charlotte Kuckuck et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 33
Urinary peptide panel for prognostic assessment of bladder cancer relapseMagdalena Krochmal, Maria Frantzi, Kim E.M. van Kessel et al.|Scientific Reports|2019Cited by 23